Brief: ReNerve Announces Strategic Partnership With Berkeley Biologics
02/06/2025 02:26
June 2 (Reuters) - ReNerve Ltd RNV.AX: STRATEGIC PARTNERSHIP WITH BERKELEY BIOLOGICS TO DEVELOP AND COMMERCIALISE 2 NEW COMPLEMENTARY TISSUE-BASED PRODUCT RANGES Source text: ID:nASX353GWB Further company coverage: RNV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Renerve
See all newsBrief: Renerve Says Positive FDA Feedback On Nervalign Nerve Guide Matrix
Brief: Renerve And Rmit Awarded A$499K Grant
Brief: ReNerve Posts Full-Year Loss Attributable Of A$5.6 Million
Brief: ReNerve Says Nervalign Nerve Cuff Receives CDSCO Marketing Approval In India
Australia's ReNerve rises on securing up to A$5 million funding facility